In Conversation

What is the presence of Boehringer Ingelheim (BI) in Southeast Asia? In 2009, Boehringer Ingelheim decided to establish a regional operating unit for its human pharmaceutical…

Can you please give our readers a brief introduction of AB SCIEX? AB SCIEX provides scientific solutions for its customers, who are scientists that are dealing…

How did you start this journey of founding your company— why medical devices and why Biosensors? I have been in the medical devices industry since 1977.…

As the CEO of EDBI since late 2008, what would you say have been the main developments of the agency during this time? EDBI is the…

Nine months ago you were appointed CEO of the company. What brought you to Dx assays? I think Dx Assays is a very interesting opportunity, which…

Why did you decide to start your own company? I started my career as a scientist with a real passion for molecular biology, and moved into…

What is the global R&D vision of Takeda, Japan’s largest pharmaceutical company that recently celebrated its 230th birthday? Takeda’s global R&D vision is committed to the…

What prompted you to found TriReme six years ago? I set up companies, so TriReme was not the first. The idea behind TriReme was to provide…

Singapore wants to be seen as a springboard for Asia, but that is a position that other countries in Asia would also like to hold. In…

Since the last time we had the pleasure of meeting you, 4 years ago, what have been the main developments and changes in the Singaporean pharmaceutical…

Central Asia, what is Central Asia in the BD perspective? For us, Central Asia includes all the countries in Asia, except Greater China, India and Japan.…

The company’s current corporate strategy includes a major focus on the Emerging Markets and Asia Pacific (EMAP) region. Concretely, what are the expectations and the main…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here